In addition Kens, none of us are any the wiser whether the TPM/daptomycin is even ready for a launch, how far it has made it through the development and testing stages, clinical trials, approvals or even if it works!
Will any of that information become known to shareholders after the arbitration outcome is provided?
Will the flagged “new” Dapto Mylan arbitration dispute prevent us from being told the above until that process is concluded? 5 more years?
.
POH Price at posting:
2.7¢ Sentiment: None Disclosure: Held
(20min delay)
